相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Rare sugars and their health effects in humans: a systematic review and narrative synthesis of the evidence from human trials
Amna Ahmed et al.
NUTRITION REVIEWS (2022)
d-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
Wanpitak Pongkan et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
MCP-1: Function, regulation, and involvement in disease
Sanjiv Singh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case-Control and Mendelian Randomization Study
Jing Li et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Mechanisms of Action of trans Fatty Acids
Antwi-Boasiako Oteng et al.
ADVANCES IN NUTRITION (2020)
d-Allulose enhances uptake of HDL-cholesterol into rat's primary hepatocyte via SR-B1
Akane Kanasaki et al.
CYTOTECHNOLOGY (2020)
Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis
Baitao Ma et al.
MOLECULAR MEDICINE REPORTS (2020)
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
Marios K. Georgakis et al.
CIRCULATION RESEARCH (2019)
The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial
Jarvis C. Noronha et al.
DIABETES OBESITY & METABOLISM (2018)
A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial
Youngji Han et al.
NUTRIENTS (2018)
Trends in the consumption of low-calorie sweeteners
Allison C. Sylvetsky et al.
PHYSIOLOGY & BEHAVIOR (2016)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Paolo Zanoni et al.
SCIENCE (2016)
Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus
Akram Hossain et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol
Mustafa Karabacak et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2015)
Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats
Akram Hossain et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
The Epidemiology of Obesity: A Big Picture
Adela Hruby et al.
PHARMACOECONOMICS (2015)
Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats
Mohammad A. Hossain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Study on the Postprandial Blood Glucose Suppression Effect of D-Psicose in Borderline Diabetes and the Safety of Long-Term Ingestion by Normal Human Subjects
Noriko Hayashi et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2010)
Failure of D-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans
Tetsuo Iida et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat
Mariana Schroeder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production
Markus Toelle et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
D-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs
Koji Murao et al.
LIFE SCIENCES (2007)
Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics
Y Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse
KF Kozarsky et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
